1
|
A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety. Eur J Pharm Sci 2019; 131:159-166. [DOI: 10.1016/j.ejps.2019.02.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2018] [Revised: 02/13/2019] [Accepted: 02/14/2019] [Indexed: 01/28/2023]
|
2
|
Gund M, Gaikwad P, Borhade N, Burhan A, Desai DC, Sharma A, Dhiman M, Patil M, Sheikh J, Thakre G, Tipparam SG, Sharma S, Nemmani KV, Satyam A. Gastric-sparing nitric oxide-releasable ‘true’ prodrugs of aspirin and naproxen. Bioorg Med Chem Lett 2014; 24:5587-5592. [DOI: 10.1016/j.bmcl.2014.10.096] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2014] [Revised: 10/18/2014] [Accepted: 10/30/2014] [Indexed: 11/29/2022]
|
3
|
Wang J, O'Sullivan S, Harmon S, Keaveny R, Radomski MW, Medina C, Gilmer JF. Design of barbiturate-nitrate hybrids that inhibit MMP-9 activity and secretion. J Med Chem 2012; 55:2154-62. [PMID: 22248361 DOI: 10.1021/jm201352k] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
We describe a new type of barbiturate-based matrix metalloproteinase (MMP) inhibitor incorporating a nitric oxide (NO) donor/mimetic group (series 1). The compounds were designed to inhibit MMP at enzyme level and to attenuate MMP-9 secretion arising from inflammatory signaling. To detect effects related to the nitrate, we prepared and studied an analogous series of barbiturate C5-alkyl alcohols that were unable to release NO (series 2). Both series inhibited recombinant human MMP-2/9 activity with nanomolar potency. Series 1 consistently inhibited the secretion of MMP-9 from TNFα/IL1β stimulated Caco-2 cells at 10 μM, which could be attributed to NO related effects because the non-nitrate panel did not affect enzyme levels. Several compounds from series 1 (10 μM) inhibited tumor cell invasion but none from the non-nitrate panel did. The work shows that MMP-inhibitory barbiturates are suitable scaffolds for hybrid design, targeting additional facets of MMP pathophysiology, with potential to improve risk-benefit ratios.
Collapse
Affiliation(s)
- Jun Wang
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | | | | | | | | | | | | |
Collapse
|
4
|
Roldós V, Cañada FJ, Jiménez-Barbero J. Carbohydrate-Protein Interactions: A 3D View by NMR. Chembiochem 2011; 12:990-1005. [DOI: 10.1002/cbic.201000705] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2010] [Indexed: 12/29/2022]
|
5
|
Lazzarato L, Donnola M, Rolando B, Chegaev K, Marini E, Cena C, Di Stilo A, Fruttero R, Biondi S, Ongini E, Gasco A. (Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins. J Med Chem 2010; 52:5058-68. [PMID: 20560642 DOI: 10.1021/jm900587h] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
A series of (nitrooxyacyloxy)methyl esters of aspirin were synthesized and evaluated as new NO-donor aspirins. Different amounts of aspirin were released in serum from these products according to the nature of nitrooxyacyloxy moiety present. In the aromatic series, there is a rather good linear correlation between the amount of aspirin released and the potencies of the products in inhibiting platelet aggregation induced by collagen. Both the native compounds and the related nitrooxy-substituted acid metabolites were able to relax rat aorta strips precontracted with phenylephrine, in keeping with a NO-induced activation of the sGC as a mechanism that underlies the vasodilator effect. The products here described are new improved examples of NO-donor aspirins containing nitrooxy groups. They could represent an alternative to the use of aspirin in a variety of clinical applications.
Collapse
Affiliation(s)
- Loretta Lazzarato
- Dipartimento di Scienza e Tecnologia del Farmaco, Universita degli Studi di Torino, Via Pietro Giuria 9, 10125 Torino, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Jones M, Inkielewicz I, Medina C, Santos-Martinez MJ, Radomski A, Radomski MW, Lally MN, Moriarty LM, Gaynor J, Carolan CG, Khan D, O’Byrne P, Harmon S, Holland V, Clancy JM, Gilmer JF. Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups. J Med Chem 2009; 52:6588-98. [DOI: 10.1021/jm900561s] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Michael Jones
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Iwona Inkielewicz
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Carlos Medina
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | | | - Anna Radomski
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Marek W. Radomski
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Maeve N. Lally
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Louise M. Moriarty
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Joanne Gaynor
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Ciaran G. Carolan
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Denise Khan
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Paul O’Byrne
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Shona Harmon
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Valerie Holland
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - John M. Clancy
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - John F. Gilmer
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| |
Collapse
|
7
|
|
8
|
Moriarty LM, Lally MN, Carolan CG, Jones M, Clancy JM, Gilmer JF. Discovery of a “True” Aspirin Prodrug. J Med Chem 2008; 51:7991-9. [DOI: 10.1021/jm801094c] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Louise M. Moriarty
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Maeve N. Lally
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Ciaran G. Carolan
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - Michael Jones
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - John M. Clancy
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| | - John F. Gilmer
- School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland
| |
Collapse
|